Business
Perimeter Medical Imaging AI Announces Closing of Non-Brokered Private Placement
Perimeter Medical Imaging AI Announces Closing of Non-Brokered Private Placement Canada...
About this update from Perimeter Medical Imaging Ai Inc
[{"type":"text","content":"\n\n\n\n Perimeter Medical Imaging AI Announces Closing of Non-Brokered Private Placement\n \n\n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n \n\n\n\n\n\n Canada NewsWire\n \n\n\n\n\n\n TORONTO\n \n and\n \n DALLAS\n \n\n ,\n \n\n Sept. 30, 2024\n \n\n /CNW/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (\"Perimeter\" or the \"Company\"), a commercial-stage medical technology company, is pleased to announce the closing of its non-brokered private placement of common shares in the capital of the Company (\"Common Shares\") announced on\n \n September 10, 2024\n \n (the \"Offering\").\n \n\n\n\n\n\n\n\n\n The Company issued 23,470,560 Common Shares at a price of\n \n $0.42\n \n per Common Share, for gross proceeds of\n \n $9,857,635\n \n . Additionally, the Company may complete one or more additional closings, for aggregate gross proceeds (together with the proceeds raised under the initial closing) of up to approximately\n \n $13.5 million\n \n . All dollar figures are quoted in Canadian dollars.\n \n\n \"We greatly appreciate the continued support and confidence shown by our investors that participated in this Offering,\" said\n \n Adrian Mendes\n \n , Perimeter's Chief Executive Officer. \"The proceeds from the financing will help us to continue driving U.S. commercial adoption of our first FDA-cleared product, Perimeter S-Series OCT, while we also advance our next-generation Perimeter B-Series OCT system, which combines propriety AI technology with OCT, toward potential commercialization in\n \n the United States\n \n .\"\n \n\n Chamath Palihapitiya, CEO of SC Master Holdings LLC (\"Social Capital'), Perimeter's single largest shareholder and the lead investor in the Offering, said, \"Surgeons have worked for years to innovate every step in the diagnosis and treatment plan for their cancer patients, with the goal of improving survivability and quality of life. Yet, intraoperative margin assessment remains one of their most pressing problems. We are pleased to continue to support Perimeter, with the hope that combining its ground-breaking OCT technology with a sur...